Authors
Loading...
Innovative postbiotic product reduces tumor cell viability and migration in breast cancer, suggesting potential therapeutic benefits.
Canani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: